Skip to main content
CE
NYSE Industrial Applications And Services

Celanese Reports Significant Full-Year Loss and Goodwill Impairment Amidst Challenging Market

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Chemical Stocks · Materials
Sentiment info
Negative
Importance info
8
Price
$57.9
Mkt Cap
$6.104B
52W Low
$35.13
52W High
$70.51
52W Position info
65% above low
Off High info
18% below high
Rel. Volume info
2.3× avg
Market data snapshot near publication time

CE sits 65% above its 52-week low of $35.13 on elevated volume (2.3× avg).

Summary

Celanese reported a substantial full-year 2025 GAAP loss of $10.44 per share, including a $1.1 billion goodwill impairment, and provided cautious Q1 2026 guidance, reflecting ongoing market challenges.


Key Events · Earnings and Guidance · CE

  • Full-Year 2025 Performance

    Reported a U.S. GAAP diluted loss per share of $10.44 and adjusted earnings per share of $3.98, with net sales decreasing 7% to $9.5 billion.

  • Significant Goodwill Impairment

    Included a $1.1 billion goodwill impairment charge, primarily impacting the Engineered Materials segment, contributing to the substantial GAAP loss.

  • Q4 2025 Results

    Posted U.S. GAAP diluted EPS of $0.23 and adjusted EPS of $0.67, with net sales of $2.2 billion, representing a 9% sequential decline.

  • Q1 2026 Guidance

    Anticipates adjusted earnings per share between $0.70 and $0.85, indicating continued modest demand and a slight sequential improvement from Q4 2025.


Analysis · CE · Industrial Applications And Services

Celanese Corporation reported a substantial full-year 2025 GAAP diluted loss per share of $10.44, primarily driven by a significant $1.1 billion goodwill impairment charge. Adjusted earnings per share also saw a considerable decline to $3.98 for the year, reflecting a 7% decrease in net sales due to lower prices and volumes. Fourth-quarter results continued this trend with sequential and year-over-year declines in sales and adjusted EPS. The company's Q1 2026 adjusted EPS guidance of $0.70-$0.85 suggests ongoing demand challenges, while the full-year 2026 free cash flow target is slightly below 2025 levels. The impairment charge indicates a re-evaluation of asset values and highlights the difficult operating environment.

How filings like this one have moved

In the 30 days to Sep 15, 2026, 35.6% of the 1100 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.43%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, CE was trading at $57.90 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $6.1B. The 52-week trading range was $35.13 to $70.51. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CE - Latest Insights

CE
Aug 31, 2026, 4:30 PM EDT
Source: BusinessWire
Importance Score:
8
Price at Filing: $45.48
Real-time Price: $45.27 info
Change: -$0.2073 (-0.46%) info
Market Cap: $4.969B info
CE
Aug 05, 2026, 4:22 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $43.38
Real-time Price: $45.27 info
Change: +$1.89 (+4%) info
Market Cap: $4.969B info
CE
Aug 04, 2026, 4:27 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $44.20
Real-time Price: $45.27 info
Change: +$1.07 (+2%) info
Market Cap: $4.969B info
CE
Aug 04, 2026, 4:23 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $44.30
Real-time Price: $45.27 info
Change: +$0.9727 (+2%) info
Market Cap: $4.969B info
CE
Aug 04, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $43.31
Real-time Price: $45.27 info
Change: +$1.96 (+5%) info
Market Cap: $4.969B info